The striking point made by him at the end of his rebuttal is an open challenge directed to the relevant Minister/official for a public debate. It seems the 'legal deck' has been cleared for such a debate to take place, and this can only open doors for organisations such as TPA in our campaigning work.
Watch this space over the next week to see if Amdipharm-Mercury Co. Ltd are able to source T3 from Europe.
The American Thyroid Association has acknowledged a shortage of levothyroxine sodium, according to a statement on their website.
STOP PRESS: The RCP's refusal to enter into further discussion has consonance with the Mid-Staffordshire Hospital Enquiry.
The Secretary of State for Health states doctors can use other thyroid hormones other than levothyroxine-only; they can prescribe unlicensed drugs; they can follow whatever guidelines they wish even if they are from another country.
Has your “Get up and Go - Got up and Gone”?
If you’re fed up and frustrated with not finding answers to your questions - then this may be the most important thyroid web site you will find.
Are you wondering who pulled the plug on your life?
Is your doctor refusing to give you a diagnosis because your thyroid function blood tests are within the so called “normal” reference range
Are you suffering the symptoms and signs of hypothyroidism or hyperthyroidism…then check out more information about this HERE
If you're not getting the help and support you need from your health care professional - please don't despair. We are very proud to have 5 qualified medical advisers + thousands of members, some of whom have exceptional experience in the field of thyroid disease. They will do whatever they can to help and support you. Now you have found us, you are no longer alone. The information and recommendations we give is free of any charge, and you will be made most welcome.
Why won't my patients get better?
Doctors Anthony Toft and Geoffrey Beckett gave a pretty accurate response to this question almost 10 years ago, and it’s still as relevant today as it was then: “It is extraordinary that more than 100 years since the first description of the treatment of hypothyroidism and the current availability of refined diagnostic tests, debate is continuing about its diagnosis and management”. [Toft A, Beckett G, BMJ 2003 (8 Feb); 325:295-296].
The views of interested, informed outsiders on how we practice medicine in the NHS are noteworthy.
A GP on an exchange visit to the UK stated “In New Zealand, I see a depressed patient perhaps once in two weeks. In the UK, it seemed that every other patient displayed depressive features”.
Matthew Par, writing in the Spectator, 28 July “An eye opening day with a busy GP” made two penetrating observations: “I was deeply struck by how great a part anxiety and depression seem to play in the apparently medical conditions of those we saw” and “What I did not see much of was, in the fullest sense, diagnosis”. So
Do we, in the UK, have more than our fair share of depression?
Are we really not much good at diagnosis?
Are 1 and 2 connected? And should we be happy with labels such as ME, Fibromyalgia, Chronic Fatigue, Sub-Fertility, “Cholesterol”, etc, which do not inform diagnoses, when properly considered research might point to diagnosis?